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Abstract
Jung JY, Woo SM, Kim WJ, Lee BN, N€or JE, Min
KS, Choi CH, Koh JT, Lee KJ, Hwang YC. Simvastatin
inhibits the expression of inflammatory cytokines and cell
adhesion molecules induced by LPS in human dental pulp
cells. International Endodontic Journal, 50, 377–386, 2017.
Aim To investigate the effect of simvastatin on
lipopolysaccharide (LPS)-stimulated inflammatory
cytokines, cell adhesion molecules and nuclear factor-
jB (NF-jB) transcription factors in human dental
pulp cells (HDPCs).
Methodology The effect of LPS and simvastatin on
human dental pulp cell (HDPCs) viability was
measured using a 3-[4, 5-dimethylthiazol-2-yl]-2, 5
diphenyltetrazolium bromide (MTT) assay. The expres-
sion of inflammatory cytokines and cell adhesion
molecules was evaluated by reverse-transcription
polymerase chain reaction (RT-PCR), enzyme-linked
immunosorbent assay (ELISA) and Western blot anal-
ysis. NF-jB transcription factors were evaluated by
Western blot analysis. Statistical analysis was
performed with analysis of variance (ANOVA).
Results The viability of cells exposed to different
concentrations of E. coli LPS, P. gingivalis LPS and
simvastatin was not significantly different compared
with that of control cells (P > 0.05). LPS significantly
increased interleukin (IL)-1b (P < 0.05) and IL-6
mRNA expression (P < 0.05) and vascular cell adhe-
sion molecule-1 (VCAM-1) (P < 0.05) and intercellu-
lar adhesion molecule-1 (ICAM-1) protein expression
(P < 0.05) in HDPCs. Treatment with simvastatin
significantly attenuated LPS-stimulated production of
IL-1b, IL-6, VCAM-1 and ICAM-1 (P < 0.05). Treat-
ment with simvastatin decreased LPS-induced expres-
sion of p65 and phosphorylation of IjB and also
significantly decreased the phosphorylation of p65
and IjB in the cytoplasm and the level of p65 in the
nucleus (P < 0.05).
Conclusions Simvastatin has a suppressing effect
on LPS-induced inflammatory cytokine, cell adhesion
molecules and NF-jB transcription factors in HDPCs.
Therefore, simvastatin might be a useful candidate as
a pulp-capping agent in vital pulp therapy.
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Caries penetration into the pulp results in bacterial inva-
sion and causes pulp inflammation (Hilton 2009) as a
result of the bacterial components and by-products.
Although this reaction represents a protective response,
it can also be destructive. Unlike other body structures,
the dental pulp is encased in a rigid hard tissue with no
collateral circulation. As a result, the pulp can become
inflamed, eventually leading to pulp necrosis (Massey
et al. 1993, Martin 2003). When the pulp becomes irre-
versibly inflamed or infected, root canal treatment is nec-
essary, and such therapy can be challenging when the
morphology of the canal is complex (Vertucci 2005).
Vital pulp therapy, such as pulp capping, partial
pulpotomy or full pulpotomy, is an alternative to
pulpectomy and can be successful (Aguilar & Lin-
suwanont 2011). Partial pulpotomy was reported to be
effective in treating permanent teeth with deep carious
lesions (Mass & Zilberman 2011), and partial pulpo-
tomy using ProRoot MTA (Dentsply Tulsa Dental,
Tulsa, OK, USA) or Dycal (L.D. Caulk, Milford, DE,
USA) led to favourable outcomes in patients with rever-
sible pulpitis (Chailertvanitkul et al. 2014). Direct pulp
capping is also of value in certain cases (Willershausen
et al. 2011) with cariously exposed pulps as well as
traumatic or mechanical pulp exposure (Matsuo et al.
1996). However, partial pulpotomy and full pulpotomy
have more predictable results than direct pulp capping
in permanent teeth with cariously exposed pulps (Agui-
lar & Linsuwanont 2011).
For vital pulp therapy to be successful when the
pulp is inflamed, the material used to cap the pulp
should have an anti-inflammatory effect and should
also induce mineralization to create a dentine bridge.
Therefore, an ideal pulp-capping agent should sup-
press inflammation and induce pulp tissue mineraliza-
tion during treatment for cariously exposed pulps
(Komabayashi & Zhu 2010). Previously, ketoprofen
was used to inhibit dental pulp inflammation in a lab-
oratory model (Choi et al. 2013). Ketoprofen is a non-
steroidal anti-inflammatory agent that is used on oral
lesion such as pharyngitis or inflammation of the
mouth in orthodontic therapy (Choi et al. 2013).
Ketoprofen has been reported to inhibit the expression
of inflammatory mediators in dental pulp cells stimu-
lated with LPS (Choi et al. 2013). However, ketopro-
fen does not have a mineralization-inducing effect on
the dental pulp (Choi et al. 2013).
Simvastatin, an HMG-CoA reductase inhibitor, has
been used to reduce the risk of cardiovascular disease.
It has an excellent tolerability profile and is associated
with a low risk of adverse effects (Pedersen & Tobert
2004, Robinson 2007). Many studies have shown that
simvastatin exerts an anti-inflammatory effect and it
has been shown to prevent the inflammatory process
induced by lipopolysaccharide (LPS) (Hernandez-
Romero et al. 2008). Atorvastatin, another HMG-CoA
reductase inhibitor, has been shown to reduce inflam-
mation through the inhibition of nuclear factor-kappa
B (NF-jB) activity (Ortego et al. 1999). In addition,
simvastatin was found to have a bone formation-pro-
moting effect in animal studies (Mundy et al. 1999).
When injected subcutaneously or administered orally,
simvastatin stimulated bone formation in mice calvaria
and increased the volume of cancellous bone in rats
(Mundy et al. 1999). Simvastatin has also been
reported to promote osteoblastic differentiation and
mineralization in MC-3T3-E1 cells (Maeda et al. 2001)
and to promote odontoblastic differentiation in human
dental pulp cells (HDPCs) (Min et al. 2010).
Therefore, although it is possible that simvastatin
could suppress inflammation in dental pulps, no study
has assessed the anti-inflammatory effect of simvas-
tatin in HDPCs. The purpose of this study was to
investigate whether simvastatin suppresses the expres-
sion of inflammatory cytokine and cell adhesion mole-
cule in HDPCs. The null hypothesis tested was that
there are no differences in the anti-inflammatory
effect between control and simvastatin-treated groups.
Material and methods
Cell isolation and culture
HDPCs were isolated from intact, caries-free supernu-
merary teeth freshly extracted from healthy children
from 7 to 10 years of age. All procedures were con-
ducted after obtaining informed consent. The study
protocol was approved by the internal review board
of the Chonnam National University Dental Hospital
(CNUDH-2013-002). Immediately after extraction, the
teeth were kept in phosphate-buffered saline and were
then split open. The pulp tissues were removed under
sterile conditions, minced with a surgical knife and
placed in 60-mm culture dishes containing a-mini-
mum essential medium (a-MEM) (Gibco Invitrogen,
Grand Island, NY, USA) supplemented with 10% foe-
tal bovine serum (FBS), 100 U mL1 of penicillin and
100 mg mL1 of streptomycin in a humidified atmo-
sphere of 5% CO2 at 37 °C. Cell passage numbers
from 3 to 4 were used for the following experiment.
Anti-inflammatory effect of simvastatin Jung et al.
© 2016 International Endodontic Journal. Published by John Wiley & Sons LtdInternational Endodontic Journal, 50, 377–386, 2017378
Cell viability assay
Cell viability wasmeasured using a 3-[4,5-dimethylthiazol-
2-yl]-2,5 diphenyltetrazo-lium bromide (MTT) assay.
For the cell viability experiments, a suspension of HDPCs
at a concentration of 1 9 105 cells per well was seeded
in 48-well plates containing a-MEM with 10% FBS. The
concentrations of Escherichia coli (E. coli) LPS (Sigma-
Aldrich, St. Louis, MO, USA) and of Porphyromonas gin-
givalis (P. gingivalis) LPS (Invivogen, San Diego, CA,
USA) were set at 0.1, 1, 10 and 20 lg mL1. The con-
centrations of simvastatin were set at 0.1, 1, 5 and
10 l mol L1. After the cells were incubated for 24 h,
MTTwas added to each well for the last 4 h of the exper-
iment, which was then stopped by the addition of
dimethyl sulfoxide (DMSO). Optical density was deter-
mined at a 570-nm wavelength on a multiwell plate
reader. Background absorbance of medium in the
absence of cells was subtracted.
Reverse-transcription Polymerase Chain Reaction
(RT-PCR)
The total RNA of dental pulp cells was extracted
using TRIzol reagent (Life Technologies, Gaithersburg,
MD, USA), according to the manufacturer’s instruc-
tions. Then, 2 lg of RNA was reverse-transcribed for
the synthesis of first-strand complementary DNA
(cDNA) (Gibco BRL, Rockville, MD, USA). The cDNA
was amplified in a final volume of 20 lL containing
2.5 mmol L1 of magnesium dichloride, 1.25 U of Ex
Taq Polymerase (Bioneer, Daejeon, Korea) and
1 mmol L1 of specific primers. Thermocycling condi-
tions consisted of 94 °C for 5 m and then 30 cycles
at 94 °C for 40 s, at 55 °C for 40 s and at 72 °C for
90 s, followed by a final 10-m extension at 72 °C.
Primer sequences for PCR are described in Table 1.
The PCR products were resolved on a 1.5% agarose
gel and stained with ethidium bromide and visualized
with a UV Transilluminator/Polaroid camera BioI-
maging System (UVP, LLC, Upland, CA, USA). PCR
results were quantified using ImageJ software, version
1.47 (National Institutes of Health, Bethesda, MD,
USA). The band density of each gene was normalized
with the density of glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as a control.
Western blot analysis
Cell lysates (50 to 100 lg) were placed in a lysis buffer
(30 m mol L1 of Tris-Cl [pH 7.5], 1% NP-40,
1 m mol L1 of EDTA, 150 m mol L1 of NaCl,
1 m mol L1 of phenylmethanesulfonyl fluoride [PMSF]
and a protease inhibitor mixture containing 1 lg mL1
of aprotinin and leupeptin), separated by 12% polyacry-
lamide gel electrophoresis and transferred to a nitrocel-
lulose membrane (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), according to the standard procedures.
The membrane was blocked in 5% nonfat dry milk and
incubated with primary antibodies for vascular cell
adhesion molecule-1 (VCAM-1) and for intercellular
adhesion molecule-1 (ICAM-1) (Santa Cruz Biotechnol-
ogy), p65 (Abcam, Cambridge, UK), and p-IjB and IjB
(Cell Signaling, Danvers, MA, USA) for 1 h at room tem-
perature. After incubation with the specific peroxidase-
coupled secondary antibodies (Thermo Scientific, Rock-
ford, IL, USA) for 1 h, the blotted bands were detected
using an enhanced chemiluminescence detection kit
(Amersham Pharmacia Biotech, Little Chalfort, UK).
Cells that had been incubated with 1 lg mL1 of
E. coli LPS or with 1 lg mL1 of P. gingivalis LPS in
the absence or presence of 5 lM of simvastatin for
24 h were harvested. The nuclear and cytoplasmic
proteins were collected by the ProteoExtract Subcellu-
lar Proteome Extraction Kit (Calbiochem, San Diego,
CA, USA). Western blot assay was performed, and the
nitrocellulose membrane was incubated overnight at
4 °C with primary antibodies for p-p65 (Cell Signal-
ing), p-65, p-IjB and IjB. After incubation with the
specific peroxidase-coupled secondary antibodies
(Thermo Scientific) for 1 h, the blotted bands were
detected using an enhanced chemiluminescence
detection kit (Amersham Pharmacia Biotech). Histone
H1 and b-actin were used as the internal controls for
the nuclear and cytoplasmic proteins, respectively.
Enzyme-linked immunosorbent assay (ELISA)
Cells were incubated with 1 lg mL1 of E. coli LPS or
with P. gingivalis LPS in the absence or presence of
5 lM of simvastatin for 24 h. The levels of IL-1b and
IL-6 were determined by means of enzyme-linked
immunosorbent assay (ELISA) kits (R&D Systems Inc,
Minneapolis, MN, USA). In all cases, a standard curve
was constructed from the standards provided by the
manufacturer. Cytokine levels were normalized to the
protein concentration in lysate.
Statistical analysis
Data were analysed using one-way analysis of vari-
ance (ANOVA), followed by the Student–Newman–Keuls
Jung et al. Anti-inflammatory effect of simvastatin
International Endodontic Journal, 50, 377–386, 2017© 2016 International Endodontic Journal. Published by John Wiley & Sons Ltd 379
test, as compared with control. Differences for which
P-values were less than 0.05 were considered statisti-
cally significant.
Results
Effects of LPS and simvastatin on viability of
HDPCs
The effect of E. coli LPS, P. gingivalis LPS and simvas-
tatin on cell viability of HDPCs is shown in Fig. 1.
The viability of cells exposed to different concentra-
tions of E. coli LPS, P. gingivalis LPS and simvastatin
was not significantly different from that of the
controls (P > 0.05).
Effects of LPS on the expression of inflammatory
cytokines and cell adhesion molecules
To investigate whether E. coli LPS and P. gingivalis
LPS induced an inflammatory reaction in HDPCs, the
expression of interleukin (IL)-1b and IL-6 was
assessed in LPS-treated HDPCs. As shown in Fig. 2a
and 2b, E. coli LPS and P. gingivalis LPS significantly
Figure 2 Effects of LPS on the expression of IL-1b, IL-6, VCAM-1 and ICAM-1 in HDPCs. The cells were treated with 0.1, 1
and 10 lg mL1 of E. coli LPS and of P. gingivalis LPS for 24 h. (a) The mRNA levels of IL-1b and IL-6 were determined by
RT-PCR. (b) The protein levels of IL-1b and IL-6 were determined with the use of ELISA kits. (c) The protein levels of VCAM-1
and ICAM-1 were determined by means of Western blot analysis. Values are expressed as means  SD of three replicates of
one representative experiment. *P < 0.05, versus control. The data shown are representative of three independent experiments
with triplicates for each experiment.
Figure 1 Effects of E. coli LPS, P. gingivalis LPS and simvastatin on cell viability of HDPCs. The MTT assay was used to assess
the viability of HDPCs for 24 h after treatment with different concentrations of (a) E. coli LPS, (b) P. gingivalis LPS and
(c) simvastatin. Values are expressed as means  SD of three replicates of one representative experiment.
Table 1 Primer sequences used for RT-PCR
Genes
GenBank
number Sequences (50–30) Length of product
IL-1b NM_000576.2 F: GATACAAACTGATGAAGCTCGTCA
R: GAGATAGTGTTTTCCACATCCTGA
172 bp
IL-6 NM_000600.3 F: GAACAAGCCAGAGCTGTCCA
R: TGAGGTGCCCATGCTACATT
230 bp
GAPDH NM_001256799 F: AGTCACGGATTT GGTCGT
R: ACAAGCTTCCCGTTCTCAG
185 bp
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increased both IL-1b and IL-6 mRNA expression and
IL-1b and IL-6 protein secretion. In addition, the
expression of cell adhesion molecules, such as VCAM-
1 and ICAM-1, was upregulated after the HDPCs were
treated with both types of LPS (Fig. 2c). Densitometry
showed that there was a significant increment in IL-
1b (P < 0.05) and IL-6 mRNA expression (P < 0.05)
and in VCAM-1 (P < 0.05) and ICAM-1 expression
(P < 0.05) after treatment with LPS, beginning at
concentrations of 0.1 lg mL1 and higher (Fig. 2).
Effects of simvastatin on LPS-upregulated
inflammatory cytokines and cell adhesion
molecules
To determine the effect of simvastatin on LPS-induced
pulpal inflammation, the expression and secretion of
cytokines such as IL-1b and IL-6 and the expression
of cell adhesion molecules such as VCAM-1 and
ICAM-1 were examined in HDPCs stimulated with
E. coli LPS or P. gingivalis LPS in the presence of sim-
vastatin for 24 h. Treatment with simvastatin
significantly attenuated the LPS-stimulated expression
of IL-1b (P < 0.05) and IL-6 (P < 0.05) in HDPCs
(Fig. 3a). The inhibitory effect of simvastatin on the
secretion of cytokines into the supernatant was
measured by ELISA. Detection of the secreted forms of
IL-1b and IL-6 confirmed that simvastatin blocked the
increments in IL-1b (P < 0.05) and IL-6 proteins
(P < 0.05) in the supernatant of LPS-stimulated
HDPCs (Fig. 3b). The effect of simvastatin on LPS-sti-
mulated IL-1b and IL-6 protein secretion corre-
sponded to its effect on mRNA expression. In
addition, upregulated VCAM-1 and ICAM-1 produc-
tion in HDPCs stimulated with LPS was inhibited by
simvastatin treatment (Fig. 3c) (P < 0.05 compared
with the E. coli LPS-treated group; P < 0.05 com-
pared with the P. gingivalis LPS-treated group).
Effects of simvastatin on LPS-stimulated NF-jB
pathway
To determine the mechanism involved in the response
to simvastatin, the effect of simvastatin on LPS-stimu-
lated NF-jB pathway was examined. Simvastatin
treatment significantly decreased LPS-induced p65
expression and phosphorylation of IjB in the whole
extract (Fig. 4a) (P < 0.05), and it also significantly
decreased LPS-increased phosphorylation of p65 and
IjB in the cytoplasm and p65 level in the nucleus
(Fig. 4b) (P < 0.05) (P < 0.05 compared with the
E. coli LPS-treated group; P < 0.05 compared with
the P. gingivalis LPS-treated group).
Discussion
Caries lesions are associated with bacterial penetra-
tion of the pulp which evoke inflammation, and even-
tually pulp necrosis and periapical pathosis (Hilton
2009). LPS, an endotoxin of gram-negative bacteria,
mediates activity of the offending organism and
induces an immune response in the host cells. LPS is
also involved in the development of dental pulp
inflammation and pulpitis. If the pulp can recover
from the inflammatory state, the inflammation is clas-
sified as reversible pulpitis. Vital pulp therapy aims to
treat reversible pulpitis and recover to a normal pulp
state (Ward 2002). For the success of vital pulp ther-
apy, factors such as age, size of exposure, state of
pulp, extra-pulpal blood clot and choice of capping
material may affect to the outcomes (Ward 2002).
Calcium hydroxide has been used as a vital pulp ther-
apy for some time (Foreman & Barnes 1990). MTA
has been used in the direct pulp capping and pulpo-
tomy and has been associated with good results
(Chailertvanitkul et al. 2014). Anti-inflammatory
agents such as corticosteroid have also been used as
pulp-capping agents (Obersztyn et al. 1968).
Simvastatin has been reported to have certain
pharmacological effects in various tissues and cell
types, including a wide range of anti-inflammatory
effects. In one study, simvastatin reduced IL-1b, IL-6
and cyclooxygenase (COX) 2 expression in human
umbilical vein endothelial cells (HUVECs) (Inoue et al.
2000), and in another report, treatment with simvas-
tatin reduced serum levels of IL-6 and TNF-a in
patients with hypercholesterolaemia (Musial et al.
2001). In an experimental model of temporo-
mandibular joint inflammation, simvastatin injected
into the joint was effective in reducing subsynovial
inflammation (George et al. 2013). Nevertheless, no
studies have been carried out to assess the potential
anti-inflammatory effect of simvastatin in human
pulp cells. In the present study, simvastatin effectively
decreased the expression of IL-1b, IL-6, and VCAM-1
and ICAM-1 induced by LPS in HDPCs. The suppres-
sive effect of simvastatin on inflammatory cytokines is
similar to that observed in other cell types, as shown
in a previous study (Inoue et al. 2000).
IL-1b, IL-6 and tumor necrosis factor-alpha (TNF-a)
are well known as key pro-inflammatory mediators in
the pathogenesis of inflammatory conditions (Green-
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hill et al. 2011, Tang et al. 2015), and LPS induces
the expression of many inflammatory cytokines, such
as IL-1b, IL-6, IL-8 and TNF-a, in HDPCs (Coli et al.
2004, Nakanishi et al. 2010, Choi et al. 2013, Kim
et al. 2015).
ICAM-1 and VCAM-1, which belong to the
immunoglobulin superfamily of cell adhesion mole-
cules, are thought to regulate the attachment and
migration of leucocytes during the inflammatory pro-
cess (Blake & Ridker 2001). It has been reported that
Figure 3 Effects of simvastatin on the expression of IL-1b and IL-6 and VCAM-1 and ICAM-1 expression induced by E. coli
LPS and P. gingivalis LPS in HDPCs. Cells were cultured with or without 1 lg mL1 of E. coli LPS or of P. gingivalis LPS for
24 h with the concentrations of simvastatin as indicated. (a) The mRNA levels of IL-1b and IL-6 were determined by RT-PCR.
(b) The protein levels of IL-1b and IL-6 were determined using ELISA kits. (c) The protein levels of VCAM-1 and ICAM-1 were
determined by means of Western blot analysis. Values are expressed as means  SD of three replicates of one representative
experiment. The data shown are representative of three independent experiments with triplicates for each experiment.
#P < 0.05, versus the E. coli LPS-treated group; +P < 0.05, versus the P. gingivalis LPS-treated group.
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these molecules are expressed in inflamed human
dental pulps and actually enhance pulp inflammation
(Sawa et al. 1998). Because bacterial components
such as LPS can induce ICAM-1 and VCAM-1 expres-
sion in dental pulp cells (Lee et al. 2008, Nakanishi
et al. 2010), IL-1b, IL-6, and ICAM-1 and VCAM-1
were used as markers of inflammation induction. LPS
increased the expression of these inflammatory cytoki-
nes in the HDPCs. This finding is in accordance with
results reported by others (Coli et al. 2004, Lee et al.
2008, Choi et al. 2013).
NF-jB is a transcription factor that binds to the
enhancer element of the immunoglobulin kappa light
chain of activated B cells (Hoesel & Schmid 2013). In
addition, the NF-jB pathway is known to be a key
mediator of genes involved in controlling cellular pro-
liferation and apoptosis. Therefore, NF-jB has an
important role in regulating cellular proliferation, and
Figure 4 Effects of simvastatin on the NF-jB pathway in HDPCs. Cells were cultured with or without 1 lg mL1 E. coli LPS or
P. gingivalis LPS for 24 h with the concentrations of simvastatin as indicated. (a) The protein expression of p65, phospho-IjB
and IjB was determined by means of Western blot analysis. (b) Protein levels of phospho-p65 and phospho-IjB in the cyto-
plasm and p65 in the nucleus of HDPCs were assessed. Values are expressed as means  SD of three replicates of one represen-
tative experiment. The data shown are representative of three independent experiments with triplicates for each experiment.
#P < 0.05, versus the E. coli LPS-treated group; +P < 0.05, versus the P. gingivalis LPS-treated group.
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activation of NF-jB can reduce apoptosis (Hoesel &
Schmid 2013).
NF-jB transcription factor also plays an essential
role in the regulation of inflammation and the
immune response. Inflammatory processes are associ-
ated with activation of the NF-jB signalling pathway
(Hoesel & Schmid 2013), so inhibition of this path-
way could have a potential role in reducing inflam-
mation (Yamamoto & Gaynor 2001). Several
transduction cascades mediate stimulation of the NF-
jB pathway. Activation of IjB kinase causes phos-
phorylation of IjB, leading to its ubiquitination and
degradation. Degradation of IjB results in the translo-
cation of NF-jB from the cytoplasm to the nucleus
where it induces the expression of specific cellular
genes (Yamamoto & Gaynor 2001).
To demonstrate the mechanism of simvastatin that
inhibits inflammatory cytokine expression, this study
examined the effect of simvastatin on the NF-jB path-
way. Simvastatin decreased the phosphorylation of
IjB and p65 in the nucleus, which had been increased
by LPS. Based on these results, the suppressive effect
of simvastatin on LPS-induced inflammatory cytokines
in HDPCs seems to be related to inhibition of the NF-
jB pathway. This finding is consistent with a previous
study of epidermal burn injury in mice showing that
simvastatin reduced inflammatory cytokine produc-
tion and apoptosis via downregulation of the TNF-a/
NF-jB pathway (Zhao et al. 2015).
Asl Aminabadi et al. (2013) assessed the use of
simvastatin versus calcium hydroxide as a pulp-cap-
ping agent, but the anti-inflammatory effect of sim-
vastatin was controversial. It is possible that their
result was related to the experimental design in that
they studied the pulp in its normal state. Under such
normal conditions, implantation materials can cause
an inflammatory response (Jegat et al. 2007). How-
ever, in the present study, LPS activated the inflam-
matory cytokines, which were reduced by treatment
with simvastatin. Moreover, in the study by Asl Ami-
nabadi et al. (2013) sodium carboxymethyl cellulose
was used as a carrier of simvastatin, and cellulose
derivatives can be degraded by bacteria (Reese et al.
1950). For the clinical application of simvastatin in
inflammatory conditions, a nondegradable carrier,
such as bioglass, would have been more appropriate.
Conclusion
Simvastatin had an anti-inflammatory effect on
LPS-induced inflammation in HDPCs. Therefore,
simvastatin might be a useful candidate as a pulp-
capping agent in vital pulp therapy.
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